Favorable outcome of secondary axillary dissection in breast cancer patients with axillary nodal relapse

Annals of Surgical Oncology

Volumn 19, Issue 4, 2012, Pages 1122-1128

  Shen, Shih Che ^a   Liao, Chien Hung ^a   Lo, Yung Feng ^a   Tsai, Hsiu Pei ^a   Kuo, Wen Lin ^a   Yu, Chi Chang ^a   Chao, Tzu Chieh ^a   Chen, Miin Fu ^a   Chang, Hsien Kun ^a   Lin, Yung Chang ^a   Shen, Wen Chi ^a   Ueng, Shir Hwa ^a   Lee, Li Yu ^a   Hsueh, Swei ^a   Huang, Yi Ting ^a   Chen, Shin Cheh ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AXILLARY LYMPH NODE; AXILLARY LYMPH NODE RECURRENCE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; PARTIAL MASTECTOMY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADULT; AGE FACTORS; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84862491203     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2082-8     Document Type: Article

References (38)

1. Fisher B, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312(11):674-81. Favorable Outcome of Secondary Dissection 1127
2. Bland KI, et al. Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a National Cancer Data Base study of patterns of omission and implications for survival. J Am Coll Surg. 1999;188(6):586-95; discussion 595-6.
3. Recht A, Houlihan MJ. Axillary lymph nodes and breast cancer: a review. Cancer. 1995;76(9):1491-512.
4. Joslyn SA, Konety BR. Effect of axillary lymphadenectomy on breast carcinomasurvival. Breast Cancer Res Treat. 2005;91(1):11-8. (Pubitemid 40684934)
5. Harris EE, et al. Prognosis after regional lymph node recurrence in patients with stage I-II breast carcinoma treated with breast conservation therapy. Cancer. 2003;98(10):2144-51. (Pubitemid 37392417)
6. Moran MS, Haffty BG. Local-regional breast cancer recurrence: prognostic groups based on patterns of failure. Breast J. 2002;8(2):81-7. (Pubitemid 34233585)
7. Fisher B, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-41. (Pubitemid 35176242)
8. Lukens JN, et al. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma. Int J Radiat Oncol Biol Phys. 2009;73(5): 1475-81.
9. Newman LA, et al. Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg. 2000;180(4):252-6.
10. Renolleau C, et al. Isolated axillary recurrences after conservative treatment of breast cancer. Eur J Cancer. 1996;32A(4):617-21.
11. Konkin DE, et al. Management and outcomes of isolated axillary node recurrence in breast cancer. Arch Surg. 2006;141(9):867-72; discussion 872-4.
12. Louis-Sylvestre C, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol. 2004;22(1):97-101. (Pubitemid 41095119)
13. Leborgne F, et al. Breast conservation treatment of early stage breast cancer: patterns of failure. Int J Radiat Oncol Biol Phys. 1995;31(4):765-75.
14. de Boer R, et al. Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg. 2001;88(1):118-22.
15. Clemons M, et al. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev. 2001;27(2):67-82. (Pubitemid 32505656)
16. Wright FC, et al. Outcomes after localized axillary node recurrence in breast cancer. Ann Surg Oncol. 2003;10(9):1054-8. (Pubitemid 40486829)
17. Berg JW. The significance of axillary node levels in the study of breast carcinoma. Cancer. 1955;8(4):776-8.
18. Chen SC, et al. Prediction of supraclavicular lymph node metastasis in breast carcinoma. Int J Radiat Oncol Biol Phys. 2002;52(3):614-9.
19. Fredriksson I, et al. Consequences of axillary recurrence after conservative breast surgery. Br J Surg. 2002;89(7):902-8. (Pubitemid 34779576)
20. Livsey JE, et al. Axillary recurrence following conservative surgery and radiotherapy in early breast cancer. Clin Oncol (R Coll Radiol). 2000;12(5):309-14.
21. Anders CK, et al. Breast cancer before age 40 years. Semin Oncol. 2009;36(3):237-49.
22. Tan BK, et al. Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm. Breast Cancer Res. 2009;11(1):R4.
23. Leong SPL, et al. Is breast cancer the same disease in Asian and Western countries? World J Surg. 2010;34(10):2308-24.
24. Foo CS, et al. Breast cancer in young Asian women: study on survival. ANZ J Surg. 2005;75(7):566-72. (Pubitemid 41002563)
25. Chia KS, et al. Do younger female breast cancer patients have a poorer prognosis? Results from a population-based survival analysis. Int J Cancer. 2004;108(5):761-5. (Pubitemid 38076409)
26. Colleoni M, et al. Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol. 2005;23(7):1390-400.
27. Zucali R, et al. Early breast cancer: evaluation of the prognostic role of the site of the primary tumor. J Clin Oncol. 1998;16(4):1363-6. (Pubitemid 28175752)
28. Lohrisch C, et al. Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer. J Clin Oncol. 2000;18(15):2828-35. (Pubitemid 30620070)
29. Fisher B, et al. Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer. 1977;39(6Suppl): 2827-39. (Pubitemid 8130398)
30. Camp RL, Rimm EB, Rimm DL. A high number of tumor-free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome. Cancer. 2000;88(1):108-13. (Pubitemid 30027685)
31. Moorman PG, et al. Prognostic significance of the number of lymph nodes examined in patients with lymph node-negative breast carcinoma. Cancer. 2001;91(12):2258-62. (Pubitemid 32552810)
32. Axelsson CK, et al. Impact on regional recurrence and survival of axillary surgery in women with node-negative primary breast cancer. Br J Surg. 2009;96(1):40-6.
33. Axelsson CK, et al. Impact of axillary dissection on staging and regional control in breast tumors B 10 mm: the DBCG experience. The Danish Breast Cancer Cooperative Group (DBCG), Rigshisoutalet, Copenhagen, Denmark. Acta Oncol. 2000;39(3):283-9. (Pubitemid 30643073)
34. Sosa JA, et al. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol. 1998;5(2):140-9. (Pubitemid 29071283)
35. Petrik DW, et al. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer. J Surg Oncol. 2003;82(2):84-90. (Pubitemid 36164441)
36. Danforth DN Jr, et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol. 1986;4(5):655-62.
37. Van Lancker M, et al. Patterns of axillary lymph node metastasis in breast cancer. Am J Clin Oncol. 1995;18(3):267-72.
38. Rauschecker H, Clark M, Gatzemeier W, Recht A. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev. 2001;(4):CD002195.